Teladoc Health (TDOC) to Release Quarterly Earnings on Wednesday

Teladoc Health (NYSE:TDOC) is scheduled to announce its earnings results after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.08. The business had revenue of $642.44 million for the quarter, compared to the consensus estimate of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. On average, analysts expect Teladoc Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Teladoc Health Price Performance

Teladoc Health stock opened at $9.00 on Wednesday. The firm’s fifty day moving average is $8.17 and its 200 day moving average is $9.97. The company has a quick ratio of 1.62, a current ratio of 1.66 and a debt-to-equity ratio of 0.66. The company has a market cap of $1.53 billion, a price-to-earnings ratio of -6.38 and a beta of 0.91. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $22.54.

Analyst Ratings Changes

TDOC has been the topic of a number of recent research reports. Canaccord Genuity Group decreased their price objective on Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research note on Friday, August 2nd. DA Davidson reduced their target price on shares of Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a research note on Thursday, August 1st. Evercore ISI lifted their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research report on Thursday, August 1st. Fifteen analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Teladoc Health presently has a consensus rating of “Hold” and a consensus target price of $11.81.

Insider Activity

In related news, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares of the company’s stock, valued at $274,049.38. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, COO Michael Willem Waters sold 6,053 shares of the business’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42. Following the transaction, the chief operating officer now directly owns 74,214 shares in the company, valued at $604,101.96. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Vidya Raman-Tangella sold 3,857 shares of the stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the completion of the sale, the insider now owns 33,667 shares of the company’s stock, valued at approximately $274,049.38. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 57,377 shares of company stock worth $438,054. 0.95% of the stock is currently owned by corporate insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.